Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M14,822Revenue $M5,816Net Margin (%)11.2Altman Z-Score5.1
Enterprise Value $M16,332EPS $1.2Operating Margin %16.6Piotroski F-Score6
P/E(ttm)27.2Beneish M-Score-2.8Pre-tax Margin (%)15.6Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %13.1Quick Ratio1.0Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %2.5Current Ratio2.0Lower Leverage y-yN
Price/Free Cash Flow26.1y-y EBITDA Growth Rate %30.1ROA % (ttm)8.7Higher Current Ratio y-yN
Dividend Yield %2.0PEG11.0ROE % (ttm)16.0Less Shares Outstanding y-yN
Payout Ratio %73.0Shares Outstanding M476ROIC % (ttm)12.0Gross Margin Increase y-yY

Gurus Latest Trades with SNN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNNKen Fisher 2015-12-31 Add$32.48 - $35.88
($34.26)
$ 31.17-9%Add 0.78%2,207,255
SNNMario Gabelli 2015-12-31 Reduce$32.48 - $35.88
($34.27)
$ 31.17-9%Reduce -2.87%6,775
SNNDavid Dreman 2015-09-30 Sold Out -0.29%$33.24 - $37.78
($35.67)
$ 31.17-13%Sold Out0
SNNKen Fisher 2015-09-30 Add0.01%$33.24 - $37.78
($35.67)
$ 31.17-13%Add 5.14%2,190,240
SNNMario Gabelli 2015-09-30 Add$33.24 - $37.78
($35.67)
$ 31.17-13%Add 9.41%6,975
SNNDavid Dreman 2015-06-30 Reduce-0.04%$33.68 - $35.8
($34.72)
$ 31.17-10%Reduce -11.73%103,704
SNNKen Fisher 2015-06-30 Reduce-0.02%$33.68 - $35.8
($34.72)
$ 31.17-10%Reduce -9.42%2,083,106
SNNMario Gabelli 2015-06-30 Reduce$33.68 - $35.8
($34.72)
$ 31.17-10%Reduce -75.36%6,375
SNNDavid Dreman 2015-03-31 Reduce-0.09%$33.44 - $36.85
($35.39)
$ 31.17-12%Reduce -21.04%117,479
SNNMario Gabelli 2015-03-31 Reduce$33.44 - $36.85
($35.39)
$ 31.17-12%Reduce -18.82%25,875
SNNKen Fisher 2015-03-31 Add$33.44 - $36.85
($35.39)
$ 31.17-12%Add 0.35%2,299,852
SNNKen Fisher 2014-09-30 Reduce-0.07%$33.16 - $36.18
($34.9)
$ 31.17-11%Reduce -28.52%2,432,882
SNNDavid Dreman 2014-09-30 Reduce$33.16 - $36.18
($34.9)
$ 31.17-11%Reduce -0.74%185,812
SNNMario Gabelli 2014-09-30 Add$33.16 - $36.18
($34.9)
$ 31.17-11%Add 59.07%38,375
SNNKen Fisher 2014-06-30 Add0.07%$29.27 - $38.91
($32.7)
$ 31.17-5%Add 36.95%3,403,562
SNNDavid Dreman 2014-06-30 Reduce-0.02%$29.27 - $38.91
($32.7)
$ 31.17-5%Reduce -4.15%187,192
SNNMario Gabelli 2014-06-30 Buy 0.0045%$29.27 - $38.91
($32.7)
$ 31.17-5%New holding24,125
SNNDavid Dreman 2014-03-31 Add0.07%$28.34 - $32.07
($30.24)
$ 31.173%Add 17.20%195,295
SNNKen Fisher 2014-03-31 Reduce-0.01%$28.34 - $32.07
($30.24)
$ 31.173%Reduce -5.85%2,485,278
SNNDavid Dreman 2013-12-31 Reduce-0.22%$24.02 - $28.74
($26.41)
$ 31.1718%Reduce -37.34%166,635
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SNN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about SNN :

Quarterly/Annual Reports about SNN:

    News about SNN:

    Articles On GuruFocus.com
    Invesco European Growth Fund Adds to 7 Stakes Jan 26 2016 
    Edwards Lifesciences a Gold Standard in the Market Dec 16 2014 
    3 Dividend Kings From The U.K. I Love To Buy Aug 21 2014 
    Stryker Corporation (SYK) Dividend Stock Analysis Jan 11 2013 
    5 Highly Predictable Mid-/Large-Caps with ROC Over 15% Apr 21 2012 
    The Best Dividends on April 18, 2012 Apr 18 2012 
    5 Healthcare Stocks to Consider Today Mar 21 2012 
    Stryker Corp. (SYK) Dividend Stock Analysis Dec 16 2011 

    More From Other Websites
    UBS Downgrades Smith & Nephew, Says Margin Upside 'Elusive' Feb 11 2016
    Smith & Nephew Plc Earnings Analysis: 2015 By the Numbers Feb 08 2016
    Why I’d Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC Feb 08 2016
    Why I'd Buy GlaxoSmithKline plc Over Smith & Nephew plc And Shire PLC Feb 08 2016
    [$$] Smith & Nephew says results prove it can rival big groups Feb 04 2016
    Smith & Nephew eyes acquisitions as sales slip Feb 04 2016
    Smith & Nephew eyes acquisitions Feb 04 2016
    Today’s Results Suggest Smith & Nephew plc Looks Set To Beat Vodafone plc Feb 04 2016
    Today's Results Suggest Smith & Nephew plc Looks Set To Beat Vodafone plc Feb 04 2016
    Smith & Nephew sees revenues up, but forex to hit margins Feb 04 2016
    Smith & Nephew sees revenues up, but forex to hit margins Feb 04 2016
    Smith & Nephew 2015 trading profit beats expectations Feb 04 2016
    BUZZ-Smith & Nephew drops as Stryker buys Sage Products Feb 01 2016
    [$$] Smith & Nephew chief executive has 'highly treatable' cancer Feb 01 2016
    Smith & Nephew boss reveals cancer diagnosis Feb 01 2016
    Smith & Nephew CEO Bohuon diagnosed with cancer Feb 01 2016
    Smith & Nephew CEO Bohuon diagnosed with cancer Feb 01 2016
    Statement regarding Olivier Bohuon Feb 01 2016
    Smith & Nephew Chief Executive Bohuon Diagnosed With Cancer Feb 01 2016
    GlaxoSmithKline plc And Smith & Nephew plc: Healthy Stock Stars For Your Portfolio! Jan 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK